Ozempic, Wegovy are getting generics as low as $15 around the world — what it means for Americans

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this ...

Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions

U.S. market will not open until patent expires in 2032, but individual generics can be sold in Canada once approved ...
The American Journal of Managed Care

FDA Approves First Generic Dapagliflozin to Reduce HF Hospitalization Risk in Type 2 Diabetes

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...
dvm360

New generic drug for bovine respiratory disease is on the market

nixiFLOR by Parnell Technologies is the first therapy approved by the FDA as bioequivalent to Resflor GOLD (Merck Animal ...
PharmTech

FDA Approves First Generic Dapagliflozin Tablets

The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...
Clinical Advisor

FDA Approves Generic Dapagliflozin for Adults With T2D

Generic dapagliflozin is now approved for adults with type 2 diabetes, though current labeling excludes chronic kidney disease and pediatric use.
ProPublica

Generic Drug Prices Are Declining, But Many Consumers Aren’t Benefiting

This article was produced in partnership with The New York Times. Not all drug prices are going up. Amid the public fury over the escalating costs of brand-name medications, the prices of generic ...
dvm360

Generic oral paste is approved by the FDA for equine gastric ulcers

Officials with the FDA have approved the first generic omeprazole oral paste for the treatment of gastric ulcers and ...
WFAE

Generic drugs are cheaper in the U.S., but quality control can be a problem, professor says

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...
Forbes

Prescribing Brand Name Drugs Instead Of Generic Drugs Costs Medicare $1.7 Billion A Year, Study Finds

The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...